Triple

T13942300
Position Surface form Disambiguated ID Type / Status
Subject Pfizer–BioNTech E335285 entity
Predicate clinicalTrialPhase3Sponsor P54032 FINISHED
Object Pfizer E108398 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pfizer | Statement: [Pfizer–BioNTech, clinicalTrialPhase3Sponsor, Pfizer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Pfizer
Context triple: [Pfizer–BioNTech, clinicalTrialPhase3Sponsor, Pfizer]
  • A. Pfizer chosen
    Pfizer is a major American multinational pharmaceutical and biotechnology corporation known for developing a wide range of prescription medicines and vaccines, including one of the first widely used COVID-19 vaccines.
  • B. Pharmaceutical Research and Manufacturers of America
    Pharmaceutical Research and Manufacturers of America is a major U.S. trade association representing leading biopharmaceutical and drug research companies.
  • C. Merck & Co.
    Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
  • D. Bristol Myers Squibb
    Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
  • E. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07 
Target predicate: clinicalTrialPhase3Sponsor
Context triple: [Pfizer–BioNTech, clinicalTrialPhase3Sponsor, Pfizer]
  • A. coordinatesClinicalTrialsFor
    Indicates that one entity organizes, manages, or oversees the planning and execution of clinical trials on behalf of another entity.
  • B. clinicalTrialPhase
    Indicates the specific phase or stage of development a clinical trial is in within the overall clinical research process.
  • C. sponsorInKeyTrials chosen
    Indicates that an entity serves as a sponsor in one or more key clinical or experimental trials involving another entity.
  • D. hasClinicalTrialsIn
    Indicates that clinical trials related to an entity are being or have been conducted in a specified location or region.
  • E. hasKeyClinicalTrial
    Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c6081b88190b53e317c3370c8fe completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2e0f6f3c8190a64058b732b0ac52 completed April 14, 2026, 12:07 p.m.
NED1 Entity disambiguation (via context triple) batch_69fba1ca49a881909e77b5a2ae13265f completed May 6, 2026, 8:17 p.m.
PD Predicate disambiguation batch_69de05a3ccf88190b45c742db483fa08 completed April 14, 2026, 9:15 a.m.
Created at: April 9, 2026, 10:17 p.m.